NCT07552389: Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus
- State
- Under way
- Phase
- Phase 3
- People
- 228 planned
- Started
- 18 Dec 2025
- Primary completion
- Dec 2028
- Arms
- Test group
- Results
- None posted
- 18 Dec 2025: Trial started
- 27 Apr 2026: Trial registered